Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00701844 · ClinicalTrials.gov registry record · NA
Sharing Our Strength: A Research Study for Bone Marrow/Stem Cell Transplant Survivors
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 315
- Enrollment target
NCT00701844: Completed NA study, sponsored by University of North Carolina, Chapel Hill.
NCT00701844 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 315 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00701844, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 315 participants
- Enrollment target
Study Summary
The Sharing Our Strength study is being conducted to help us understand people's experiences with hematopoietic stem cell transplantation and to test a new program designed to help people recover physically and emotionally after transplant.
Interventions
- BEHAVIORAL Writing A (Experimental informative writing)
- BEHAVIORAL Writing B (Experimental noninformative writing)
- BEHAVIORAL Writing C (Control informative writing)
- BEHAVIORAL Writing D (Control noninformative writing)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 315 participants |
| Start Date | 2007-07 |
| Est. Completion | 2011-09 |
| Phase | NA |
What the finished NCT00701844 record still lists
NCT00701844 is an interventional study that assigns participants to a tested intervention. The registered 315 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower).
The record links to 0 conditions, and to 4 interventions - of which Writing A (Experimental informative writing) is the first listed.
NCT00701844 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00701844 about?
NCT00701844 is a clinical study titled "Sharing Our Strength: A Research Study for Bone Marrow/Stem Cell Transplant Survivors". The Sharing Our Strength study is being conducted to help us understand people's experiences with hematopoietic stem cell transplantation and to test a new program designed to help people recover physically and emotionally after transplant.
What is the current status of trial NCT00701844?
This trial is currently completed. It is a NA study. The enrollment target is 315 participants. The study started on 2007-07. Estimated completion is 2011-09.
What interventions are being tested in trial NCT00701844?
The interventions under investigation include: Writing A (Experimental informative writing) (BEHAVIORAL), Writing B (Experimental noninformative writing) (BEHAVIORAL), Writing C (Control informative writing) (BEHAVIORAL), Writing D (Control noninformative writing) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00701844?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00701844's enrollment target sits among peer trials
315 323rd of 2000 higher than 1,678 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04812366 · 315 participants · Phase 2
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
- NCT05101460 · 315 participants
An All Comers Registry For Normothermic Ex Vivo Lung Perfusion (EVLP) as Assessment of Donor Lungs for Transplant
- NCT05897320 · 315 participants · Phase 3
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
- NCT06439082 · 315 participants · Phase 3
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia